Initial Clinical Experience with the 4-F Self-expanding XPERT Stent System for Infrapopliteal Treatment of Patients with Severe Claudication and Critical Limb Ischemia

Kickuth, Ralph; Keo, Hak Hong; Triller, J; Ludwig, K.; Do, Dai-Do

doi:10.1016/j.jvir.2007.03.012

Cited by 47 publications

(18 citation statements)

References 34 publications

(32 reference statements)

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…1,2,4,5 In many vascular beds, including coronary, carotid, renal, iliac, and infrainguinal arteries, the long-term patency of PTA can be augmented by intravascular stenting. Similarly, several clinical studies are now available that suggest that tibial stents enhance acute results by providing "rescue" in cases of dissection or acute occlusion (ie, "bailout stenting") 23,24 and may be appropriate as primary therapy in selected patients. 18,25,26 Whether primary stenting improves patency in all patients remains controversial, because in-stent restenosis continues to be a significant problem 4 and available comparative clinical studies have been small and the results conflicting.…”

Section: Discussionmentioning

confidence: 99%

Randomized comparison of everolimus-eluting versus bare-metal stents in patients with critical limb ischemia and infrapopliteal arterial occlusive disease

Bosiers

Scheinert²,

Peeters

et al. 2012

Journal of Vascular Surgery

242

196

View full text Add to dashboard Cite

show abstract

Section: Discussionmentioning

confidence: 99%

Randomized comparison of everolimus-eluting versus bare-metal stents in patients with critical limb ischemia and infrapopliteal arterial occlusive disease

Bosiers

Scheinert²,

Peeters

et al. 2012

Journal of Vascular Surgery

242

196

View full text Add to dashboard Cite

show abstract

“…These authors obtained a primary patency of 85.4% at 6 months and of 64.8% at 12 months. As for stents implanted in the popliteal segment, Kickuth et al 18 studied 35 patients with intermittent claudication and critical limb ischemia, in which auto-expandable nitinol stents were implanted in the popliteal artery. In 22 cases, stents were implanted in the distal portion of the popliteal artery, and in the other cases, in the tibiofibular trunk, with a primary patency rate of 82% and a limb salvage rate of 100%.…”

Section: Discussionmentioning

confidence: 99%

Outcomes of the Use of a Superflexible Nitinol Stent in the Popliteal Artery

Rodrigues¹,

Metzger²,

Rossi³

et al. 2014

Revista Brasileira de Cardiologia Invasiva (English Version)

View full text Add to dashboard Cite

Background:The long-term primary patency rates for percutaneous transluminal angioplasty using first and second generation stents for the treatment of the popliteal artery have been disappointing. However, results with the new nitinol stents seem promising. Our objective was to evaluate short-term clinical outcomes using the superflexible nitinol stent in the treatment of atherosclerotic lesions in popliteal segments. Methods: Retrospective longitudinal study conducted from April to December 2013. Population characteristics, procedure-related data and imaging tests were assessed at 6 months. Stent patency and limb salvage rates were obtained. Results: A total of 14 patients with mean age of 73 ± 11 years were included, of which 50% were male and 64.3% diabetic. All patients had trophic lesions in the treated limbs. The arteriographic lesions were classified according to the criteria of the Trans-Atlantic Inter-Society Consensus (TASC) criteria as TASC B and C inequal proportions. In the assessment of below-the-knee runoff, 78.6% of the patients had only one distal pervious artery, of which the fibular artery was the most frequently observed. The stent landing zone was the mid segment of the popliteal artery in 57.1% of the cases and the distal segment, crossing the knee joint, in the remaining patients. During the 6 month follow-up there were no stent fractures. The primary patency rate was 85.7% and the limb salvage rate was 100%. Conclusions: In our study, angioplasty using the super flexible nitinol stent demonstrated to be safe and effective for the treatment of atherosclerotic lesions of the popliteal artery.

show abstract

“…With advances in endovascular therapy and technologies, together with the development of specifically designed materials for infrapopliteal arteries, [24][25][26] such as absorbable, carbofilm-coated, and coronary drug-eluting stents, 6,27,28 interest in primary and secondary stent-supported BTK angioplasty for CLI has increased. In a meta-analysis published in 2008 with 640 patients with predominantly straight in-line arterial flow treatment, the primary patency rate was 78.9%, the limb salvage rate was 96.4%, and Rutherford class improved in 91.3%.…”

Section: Discussionmentioning

confidence: 99%

Bifurcated coronary stents for infrapopliteal angioplasty in critical limb ischemia

Silingardi

Tasselli

Cataldi

et al. 2013

Journal of Vascular Surgery

View full text Add to dashboard Cite

Preliminary data suggest that the Nile Croco bifurcated stent for below-the-knee angioplasty in selected patients with CLI is associated with high rates of technical success, early and midterm patency, and clinical improvement. Limb salvage rates are acceptable for this technically highly challenging anatomy, yet further studies with larger patient populations are necessary to validate these results.

show abstract

Initial Clinical Experience with the 4-F Self-expanding XPERT Stent System for Infrapopliteal Treatment of Patients with Severe Claudication and Critical Limb Ischemia

Cited by 47 publications

References 34 publications

Randomized comparison of everolimus-eluting versus bare-metal stents in patients with critical limb ischemia and infrapopliteal arterial occlusive disease

Randomized comparison of everolimus-eluting versus bare-metal stents in patients with critical limb ischemia and infrapopliteal arterial occlusive disease

Outcomes of the Use of a Superflexible Nitinol Stent in the Popliteal Artery

Bifurcated coronary stents for infrapopliteal angioplasty in critical limb ischemia

Contact Info

Product

Resources

About